论文部分内容阅读
Subgroup analysis arises in clinical trials research when we wish to estimate a treatment effect on a specific subgroup of the population distinguished by a biomarker at baseline.Many trial designs induce latent subgroups such that subgroup membership is observable in one arm of the trial and unidentified in the other.